|
25.07.2018 22:05:48
|
Vertex Pharmaceuticals Inc. Q2 adjusted earnings Beat Estimates
(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX) reported a profit for its second quarter that advanced from the same period last year.
The company's earnings came in at $207 million, or $0.80 per share. This compares with $18 million, or $0.07 per share, in last year's second quarter.
Excluding items, Vertex Pharmaceuticals Inc. reported adjusted earnings of $244 million or $0.94 per share for the period.
Analysts had expected the company to earn $0.75 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 45.9% to $750 million from $514 million last year.
Vertex Pharmaceuticals Inc. earnings at a glance:
-Earnings (Q2): $244 Mln. vs. $99 Mln. last year. -EPS (Q2): $0.94 vs. $0.39 last year. -Analysts Estimate: $0.75 -Revenue (Q2): $750 Mln vs. $514 Mln last year.
-Guidance: Full year revenue guidance: $2.9 to $3.0 Bln
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Vertex Pharmaceuticals Inc.mehr Nachrichten
Analysen zu Vertex Pharmaceuticals Inc.mehr Analysen
Aktien in diesem Artikel
| Vertex Pharmaceuticals Inc. | 448,35 | -0,58% |
|
Letzte Top-Ranking Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.